| Branched-chain amino acid metabolism in cancer |
33 |
| How to best assess abdominal obesity |
19 |
| Dietary vitamin D, vitamin D receptor, and microbiome |
17 |
| Cysteine-derived hydrogen sulfide and gut health: a matter of endogenous or bacterial origin |
17 |
| Breastfeeding and neurodevelopmental outcomes |
13 |
| Sarcopenia and obesity |
12 |
| Human milk composition and infant growth |
12 |
| Intermittent versus continuous feeding in critically ill adults |
11 |
| Hyperammonemia and proteostasis in cirrhosis |
11 |
| Bioelectrical impedance analysis in the assessment of sarcopenia |
11 |
| Metformin: old friend, new ways of action-implication of the gut microbiome? |
10 |
| Can the critically ill patient generate sufficient energy to facilitate exercise in the ICU? |
9 |
| Omega-3 fatty acids and nonalcoholic fatty liver disease in adults and children: where do we stand? |
9 |
| Dietary carbohydrates and fatty liver disease: de novo lipogenesis |
9 |
| The relevance of dietary protein after bariatric surgery: what do we know? |
9 |
| Diabetes and frailty |
9 |
| Sarcopenic obesity in fatty liver |
9 |
| Emerging outcome measures for nutrition trials in the critically ill |
8 |
| Dietary patterns and cognition in older persons |
8 |
| The manifold role of the mitochondria in skeletal muscle insulin resistance |
8 |
| Low-carbohydrate diets for the treatment of obesity and type 2 diabetes |
8 |
| The intestinal microbiome and its relevance for functionality in older persons |
8 |
| Effects of chromium supplementation on body composition, human and animal health, and insulin and glucose metabolism |
8 |
| Using trehalose to prevent and treat metabolic function: effectiveness and mechanisms |
7 |
| Resveratrol for patients with chronic obstructive pulmonary disease: hype or hope? |
7 |
| Nutriepigenetics and cardiovascular disease |
7 |
| The emerging role of ketogenic diets in cancer treatment |
7 |
| Should we consider subcellular compartmentalization of metabolites, and if so, how do we measure them? |
7 |
| Telomere length as a biomarker of accelerated aging: is it influenced by dietary intake? |
7 |
| The final word on nutritional screening and assessment in older persons |
7 |
| Ketone bodies as epigenetic modifiers |
7 |
| Spaceflight-related ocular changes: the potential role of genetics, and the potential of B vitamins as a countermeasure |
7 |
| Strategies to improve bioavailability of omega-3 fatty acids from ethyl ester concentrates |
6 |
| Microbiota and nonalcoholic fatty liver disease: promising prospects for clinical interventions? |
6 |
| Beneficial effects of walnut consumption on human health: role of micronutrients |
6 |
| Fish oil-derived n-3 polyunsaturated fatty acids for the prevention and treatment of sarcopenia |
6 |
| Mechanisms regulating brain docosahexaenoic acid uptake: what is the recent evidence? |
5 |
| Placental fatty acid transfer |
5 |
| Long-chain omega-3 fatty acids and cancer: any cause for concern? |
5 |
| Fatty acid-binding proteins: functional understanding and diagnostic implications |
5 |
| Curcumin and arterial function in health and disease: impact on oxidative stress and inflammation |
5 |
| Updates in nutrition and polypharmacy |
5 |
| Fast digestive proteins and sarcopenia of aging |
5 |
| Nutritional interventions to improve recovery from postoperative ileus |
5 |
| Carbohydrates and cognitive function |
5 |
| Early influencing factors on the development of sensory and food preferences |
5 |
| Human milk protein vs. formula protein and their use in preterm infants |
4 |
| Glutamine and type 1 diabetes mellitus: is there a role in glycemic control? |
4 |
| Emerging role for kynurenines in metabolic pathologies |
4 |
| Probiotics and mucositis |
4 |
